Skip to main content
NewslettersWatchlist

Sirona Biochem Corp(SBM-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.055
Day High0.060
Open:0.055
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

TOP STORIES: Sirona Biochem Corp

Select a category then submit the form to load news
GlobeNewswire
Sirona Biochem Announces Debenture Financing
GlobeNewswire
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
PR Newswire
Canadian Investment Regulatory Organization Trading Halt - SBM
AI-generated - The Globe and Mail
Sirona Biochem: Top 10 Undervalued Biotechnology Industry Stocks (SBM)
AI-generated - The Globe and Mail
Sirona Biochem: Top 10 Undervalued Biotechnology Industry Stocks (SBM)
GlobeNewswire
Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare’s Landmark Report
GlobeNewswire
Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology
AI-generated - The Globe and Mail
Sirona Biochem: Top 10 Undervalued Biotechnology Industry Stocks (SBM)
TheNewswire.com
Update: Stonegate Initiates Coverage on Sirona Biochem Corp (TSX-V:SBM)
GlobeNewswire
SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout
AI-generated - The Globe and Mail
Sirona Biochem: Top 10 Undervalued Biotechnology Industry Stocks (SBM)
AI-generated - The Globe and Mail
Sirona Biochem: Top 10 Undervalued Biotechnology Industry Stocks (SBM)
GlobeNewswire
GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report
GlobeNewswire
Sirona Biochem Engages Stonegate Healthcare Partners
GlobeNewswire
SIRONA BIOCHEM Corporate Update April 2024
GlobeNewswire
Sirona Biochem Announces Close of Private Placement
GlobeNewswire
Sirona Biochem Announces 2023 Annual Meeting Results
GlobeNewswire
Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations
GlobeNewswire
Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim™ in Early 2025
GlobeNewswire
Sirona Biochem Provides Update on Loan
GlobeNewswire
Sirona Biochem Engages Global Beauty Consulting
GlobeNewswire
Sirona Biochem Announces Loan
GlobeNewswire
Sirona Biochem Initiates Private Placement
GlobeNewswire
CORRECTION -- Sirona Biochem Corporate Update January 2024
GlobeNewswire
Sirona Biochem Corporate Update January 2024
GlobeNewswire
Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories™
GlobeNewswire
Sirona Biochem Initiates GlycoProteMim™ Trademark for Anti-Aging Molecule TFC-1326
GlobeNewswire
Sirona Biochem Announces Change of Auditor
GlobeNewswire
Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
GlobeNewswire
Sirona Biochem Corporate Update
GlobeNewswire
Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB
Globe Newswire
Sirona Biochem Corporate Update

Profile

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2025.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2025 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.